This is a major study that is now being launched. This is the first study of its kind and is specifically directed toward understanding how environmental factors and the gut microorganisms influence IBD flare and recovery. For the PREdiCCt study we hope to recruit 1500 people in remission from Crohn’s disease or ulcerative colitis (illness under control) from 28 inflammatory bowel disease clinics across the UK.
Chief Investigator: Dr Charlie Lees
Number and location of participating sites (by region/ country): UK, 20-25 sites (anticipated)
ISRCTN number: ISRCTN67248113
Funders: Chief Scientist Office (Scottish Government), Cure Crohn’s and Colitis, Crohn’s and colitis in childhood, Edinburgh and Lothian Health Fund
Start and End date
Of grant award: Nov 2016 - Nov 2019
Current status: Recruitment complete - now closed
Website: www.predicct.co.uk
PREdiCCt poster:
UK GDPR Privacy Statement: If you have participated in this study and would like to read how it complies with UK GDPR, please read this document.
Sponsor: University of Edinburgh/NHS Lothian (ACCORD) http://www.accord.ed.ac.uk/
Chief Investigator: Dr Charlie Lees (CI), Gastroenterology department, Western General Hospital, Crewe Road South, Edinburgh, EH4 2XU. Charlie.Lees@ed.ac.uk
Trial manager: Lisa Derr Email: predicct@ed.ac.uk
ECTU involvement: Trial Management, Statistics, Database, Data management
(UKCRC)